Author

Y. Tabe

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

T. Ai· 2 shared A. A. Sherif· 1 shared A. Khasawneh· 1 shared A. Ohsaka· 1 shared C. Ono· 1 shared D. M. Standley· 1 shared D. S. Saputri· 1 shared F. J. Paran· 1 shared

Activity by Year

2018-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

T. Ai

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BCR, not TCR, repertoire diversity is associated with favorable COVID-19 prognosis

F. J. Paran, R. Oyama, A. Khasawneh, T. Ai, H. S. Ismanto, A. A. Sherif, D. S. Saputri, C. Ono, M. Saita, S. Takei, Y. Horiuchi, K. Yagi, Y. Matsuura, Y. Okazaki, K. Takahashi, , T. Naito

This study finds that BCR repertoire diversity, not TCR diversity, correlates with favorable outcomes in COVID-19 patients.

bioRxiv · Jun 11, 2024Immunology

A new highly sensitive real-time quantitative-PCR method for detection of BCR-ABL1 to monitor minimal residual disease in chronic myeloid leukemia after discontinuation of imatinib

Y. Tabe, H. Kitamura, K. Tsuchiya, M. Yuri, T. Ai, S. Misawa, T. Horii, A. Ohsaka, S. Kimura

This paper develops a new in-house RQ-PCR method for detecting BCR-ABL1 transcripts in CML patients, showing higher sensitivity than commercial methods for monitoring minimal residual disease.

bioRxiv · Oct 29, 2018Cancer Biology